Track the Shanghai Bio-heart Biological Technology Co., Ltd. - B share price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares are listed on HK HK, under the supervision of HKEX. Operating in the Health Care sector, Shanghai Bio-heart Biological Technology Co., Ltd. - B has recorded 21 public disclosures. Market capitalisation: €727.8m. The latest transaction was disclosed on 15 May 2026 (Purchase). Among the most active insiders: Wang Philip Li. Every trade is free.
21
Insider Decl.
0
Thresholds
€99,815
21 ops.
Buy Volume
·
0 ops.
Sell Volume
14Σ signal
Buys €99,815· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 22,213 of 26,212 companies
26.8
score / 100
Value
16
Quality
38
FCF yld-10%
Earn yld-9.6%
EV/EBITDA·
ROE-11%
Gross mgn40%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
10,000 shares@ HK$4.260.0051% mcap4.6% of flowShareXHKGHKEX:DA20260416E00579
Ideal exit: 10 Jan 2027 (T+270)
21 of 21 declarations
About Shanghai Bio-heart Biological Technology Co., Ltd. - B
Shanghai Bio-heart Biological Technology Co., Ltd. is a company focused on developing biological technologies for the healthcare sector. It is listed on the Hong Kong Stock Exchange.